These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 12641616

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
    Morel F, Bris MJ, Herry A, Calvez GL, Marion V, Abgrall JF, Berthou C, Braekeleer MD.
    Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction.
    Stentoft J, Pallisgaard N, Kjeldsen E, Holm MS, Nielsen JL, Hokland P.
    Eur J Haematol; 2001 Apr; 67(5-6):302-8. PubMed ID: 11872078
    [Abstract] [Full Text] [Related]

  • 28. [Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia].
    Zhu Y, Pan LQ, Qian SX, Song P, Yu H, Zhang SJ, Ge Z, Hong M, Tian T, Li JY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):581-6. PubMed ID: 23815902
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy.
    Cortes JE, Talpaz M, Giles F, O'Brien S, Rios MB, Shan J, Garcia-Manero G, Faderl S, Thomas DA, Wierda W, Ferrajoli A, Jeha S, Kantarjian HM.
    Blood; 2003 May 15; 101(10):3794-800. PubMed ID: 12560227
    [Abstract] [Full Text] [Related]

  • 32. Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia.
    Sureda A, Carrasco M, de Miguel M, Martínez JA, Conde E, Sanz MA, Díaz-Mediavilla J, Sierra J.
    Haematologica; 2003 Nov 15; 88(11):1213-20. PubMed ID: 14607749
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Bone marrow morphological changes in patients of chronic myeloid leukemia treated with imatinib mesylate.
    Joshi S, Sunita P, Deshmukh C, Gujral S, Amre P, Nair CN.
    Indian J Cancer; 2008 Nov 15; 45(2):45-9. PubMed ID: 18626147
    [Abstract] [Full Text] [Related]

  • 35. Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.
    Sillaber C, Mayerhofer M, Agis H, Sagaster V, Mannhalter C, Sperr WR, Geissler K, Valent P.
    Wien Klin Wochenschr; 2003 Aug 14; 115(13-14):485-504. PubMed ID: 13677268
    [Abstract] [Full Text] [Related]

  • 36. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
    Cohen MH, Johnson JR, Pazdur R.
    Clin Cancer Res; 2005 Jan 01; 11(1):12-9. PubMed ID: 15671523
    [Abstract] [Full Text] [Related]

  • 37. The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML.
    O'Dwyer ME, Mauro MJ, Kurilik G, Mori M, Balleisen S, Olson S, Magenis E, Capdeville R, Druker BJ.
    Blood; 2002 Sep 01; 100(5):1628-33. PubMed ID: 12176881
    [Abstract] [Full Text] [Related]

  • 38. Targeted chronic myeloid leukemia therapy: Seeking a cure.
    Fausel C.
    Am J Health Syst Pharm; 2007 Dec 15; 64(24 Suppl 15):S9-15. PubMed ID: 18056932
    [Abstract] [Full Text] [Related]

  • 39. Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantation.
    Agis H, Mannhalter C, Sperr WR, Keil F, Kalhs P, Pirc-Danoewinata H, Krauth MT, Haas OA, Geissler K, Lechner K, Valent P.
    Leuk Lymphoma; 2004 Jul 15; 45(7):1453-8. PubMed ID: 15359647
    [Abstract] [Full Text] [Related]

  • 40. Dasatinib treatment for imatinib resistant or intolerant patients with chronic myeloid leukaemia.
    Li J, Xu G, Yu S, He L, Guo L.
    J Int Med Res; 2011 Jul 15; 39(2):337-47. PubMed ID: 21672337
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.